{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:41:13Z","timestamp":1760550073520},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Clean Competition Consortium"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Since its discovery in the 1970s, prostate-specific antigen (PSA) has become widely known as a biomarker of prostate cancer in males but has often been overlooked in female malignancies. Although the serum concentration of PSA differs between men and women by about 1000-fold, studies have suggested that PSA concentrations drastically differ among healthy females and those who exhibit increased androgen production.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONTENT<\/jats:title>\n                  <jats:p>There have been reports of increased PSA expression in women exhibiting hyperandrogenic states, including polycystic ovary syndrome and hirsutism, as well as marked increases in a subset of breast cancer patients. These findings have not only revealed the remarkable diagnostic potential of PSA in a diverse range of clinical conditions but also point to its potential of becoming a useful biomarker of steroid hormone doping among female athletes. Recently, highly sensitive assays that can measure PSA at low limits of detection have been developed, which will aid in the discrimination of PSA between these different conditions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY<\/jats:title>\n                  <jats:p>The overall aim of this review is to revisit the expression of PSA in hormonally-regulated tissues and in female malignancies, and to demonstrate how the regulation of PSA permits its use in antidoping initiatives.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1373\/clinchem.2016.256198","type":"journal-article","created":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T02:54:18Z","timestamp":1465008858000},"page":"1066-1074","source":"Crossref","is-referenced-by-count":10,"title":["Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping"],"prefix":"10.1093","volume":"62","author":[{"given":"Natasha","family":"Musrap","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftherios P","family":"Diamandis","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"2020022605342897900_B1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.beem.2006.02.004","article-title":"Diagnosis of hyperandrogenism: clinical criteria","volume":"20","author":"Yildiz","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020022605342897900_B2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5507\/bp.2014.046","article-title":"Prostate specific antigen. Current clinical application and future prospects","volume":"159","author":"Duskova","year":"2015","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"2020022605342897900_B3","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1210\/jcem.86.4.7378","article-title":"Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome","volume":"86","author":"Obiezu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022605342897900_B4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/clinchem\/46.6.859","article-title":"Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals","volume":"46","author":"Obiezu","year":"2000","journal-title":"Clin Chem"},{"key":"2020022605342897900_B5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bios.2015.02.026","article-title":"Silver nanoprism etching-based plasmonic ELISA for the high sensitive detection of prostate-specific antigen","volume":"69","author":"Liang","year":"2015","journal-title":"Biosens Bioelectron"},{"key":"2020022605342897900_B6","first-page":"2012","article-title":"Abstract 2012: Accurate measurement of free and complexed PSA concentrations in serum of women using a novel technology with fg\/mL sensitivity [Abstract]","volume-title":"Cancer Res","author":"Nikolenko","year":"2015"},{"key":"2020022605342897900_B7","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1515\/cclm-2015-0982","article-title":"A replacement for the testosterone \u201csex gap\u201d","volume":"54","author":"Diamandis","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2020022605342897900_B8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1043-2760(98)00082-4","article-title":"Prostate-specific antigen: its usefulness in clinical medicine","volume":"9","author":"Diamandis","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"2020022605342897900_B9","first-page":"3983","article-title":"Prostate specific antigen\u2013new applications in breast and other cancers","volume":"16","author":"Diamandis","year":"1996","journal-title":"Anticancer Res"},{"key":"2020022605342897900_B10","first-page":"41","article-title":"The normal female and the male breast epithelium does not express prostate-specific antigen. Preliminary immunohistochemical observations of autopsy breast tissues","volume":"18","author":"Zaviacic","year":"1999","journal-title":"Gen Physiol Biophys"},{"key":"2020022605342897900_B11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0094-0143(05)70373-6","article-title":"Nonprostatic sources of prostate-specific antigen","volume":"24","author":"Diamandis","year":"1997","journal-title":"Urol Clin North Am"},{"key":"2020022605342897900_B12","first-page":"1603","article-title":"Expression of the prostate-specific antigen gene by a primary ovarian carcinoma","volume":"55","author":"Yu","year":"1995","journal-title":"Cancer Res"},{"key":"2020022605342897900_B13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jcla.1860090209","article-title":"Prostate-specific antigen expression by various tumors","volume":"9","author":"Levesque","year":"1995","journal-title":"J Clin Lab Anal"},{"key":"2020022605342897900_B14","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0022-5347(01)66156-1","article-title":"The periurethral glands do not significantly influence the serum prostate specific antigen concentration","volume":"155","author":"Oesterling","year":"1996","journal-title":"J Urol"},{"key":"2020022605342897900_B15","first-page":"467","article-title":"Serum total and free prostate-specific antigen for breast cancer diagnosis in women","volume":"6","author":"Black","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2020022605342897900_B16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0009-9120(94)90015-9","article-title":"Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age","volume":"27","author":"Yu","year":"1994","journal-title":"Clin Biochem"},{"key":"2020022605342897900_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006380306781","article-title":"The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast","volume":"59","author":"Black","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"2020022605342897900_B18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-006-9312-y","article-title":"Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines","volume":"102","author":"Paliouras","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"2020022605342897900_B19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00666006","article-title":"Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines","volume":"32","author":"Yu","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2020022605342897900_B20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/mend.11.2.9883","article-title":"An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter","volume":"11","author":"Cleutjens","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2020022605342897900_B21","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1074\/jbc.271.11.6379","article-title":"Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter","volume":"271","author":"Cleutjens","year":"1996","journal-title":"J Biol Chem"},{"key":"2020022605342897900_B22","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1074\/jbc.270.12.6615","article-title":"Oral contraceptive-induced expression of prostate-specific antigen in the female breast","volume":"270","author":"Yu","year":"1995","journal-title":"J Biol Chem"},{"key":"2020022605342897900_B23","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1200\/JCO.2001.19.12.3160","article-title":"Prostate-specific antigen levels in nipple aspirate fluid","volume":"19","author":"Sauter","year":"2001","journal-title":"J Clin Oncol"},{"key":"2020022605342897900_B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"key":"2020022605342897900_B25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199608293350909","article-title":"Insulin and the polycystic ovary syndrome","volume":"335","author":"Utiger","year":"1996","journal-title":"N Engl J Med"},{"key":"2020022605342897900_B26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF03344101","article-title":"Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome","volume":"29","author":"Burelli","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"2020022605342897900_B27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12020-008-9130-6","article-title":"Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome","volume":"35","author":"Ukinc","year":"2009","journal-title":"Endocrine"},{"key":"2020022605342897900_B28","first-page":"999","article-title":"Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome","volume":"16","author":"Mardanian","year":"2011","journal-title":"J Res Med Sci"},{"key":"2020022605342897900_B29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejogrb.2014.05.006","article-title":"The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs)","volume":"179","author":"Bili","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020022605342897900_B30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/jcem.82.3.3792","article-title":"Prostate-specific antigen in female serum, a potential new marker of androgen excess","volume":"82","author":"Melegos","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022605342897900_B31","first-page":"81","article-title":"Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women","volume":"85","author":"Negri","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022605342897900_B32","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1210\/jcem.83.7.4960","article-title":"The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function","volume":"83","author":"Escobar-Morreale","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022605342897900_B33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jnci\/89.8.587","article-title":"Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts","volume":"89","author":"Borchert","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"2020022605342897900_B34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1373\/clinchem.2006.067041","article-title":"Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals","volume":"52","author":"Slagter","year":"2006","journal-title":"Clin Chem"},{"key":"2020022605342897900_B35","first-page":"6344","article-title":"Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors","volume":"54","author":"Monne","year":"1994","journal-title":"Cancer Res"},{"key":"2020022605342897900_B36","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/bjc.1995.401","article-title":"Prostate-specific antigen in serum of women with breast cancer","volume":"72","author":"Giai","year":"1995","journal-title":"Br J Cancer"},{"key":"2020022605342897900_B37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-9120(96)00014-E","article-title":"Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer","volume":"29","author":"Melegos","year":"1996","journal-title":"Clin Biochem"},{"key":"2020022605342897900_B38","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/bjc.1997.512","article-title":"Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases","volume":"76","author":"Borchert","year":"1997","journal-title":"Br J Cancer"},{"key":"2020022605342897900_B39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/clinchem\/42.5.675","article-title":"Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers","volume":"42","author":"Ferguson","year":"1996","journal-title":"Clin Chem"},{"key":"2020022605342897900_B40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ijc.11607","article-title":"Association of kallikrein expression in nipple aspirate fluid with breast cancer risk","volume":"108","author":"Sauter","year":"2004","journal-title":"Int J Cancer"},{"key":"2020022605342897900_B41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/(SICI)1097-0142(19990215)85:4<891::AID-CNCR17>3.0.CO;2-K","article-title":"Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma","volume":"85","author":"Diamandis","year":"1999","journal-title":"Cancer"},{"key":"2020022605342897900_B42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.canep.2013.06.009","article-title":"Serum level of prostate-specific antigen (PSA) in women with breast cancer","volume":"37","author":"Mashkoor","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"2020022605342897900_B43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/2008-7802.151824","article-title":"Is serum prostate-specific antigen a diagnostic marker for benign and malignant breast tumors in women?","volume":"6","author":"Razavi","year":"2015","journal-title":"Int J Prev Med"},{"key":"2020022605342897900_B44","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1373\/clinchem.2011.170290","article-title":"Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology","volume":"58","author":"McDermed","year":"2012","journal-title":"Clin Chem"},{"key":"2020022605342897900_B45","doi-asserted-by":"crossref","first-page":"18437","DOI":"10.1073\/pnas.0904719106","article-title":"Nanoparticle-based bio-barcode assay redefines \u201cundetectable\u201d PSA and biochemical recurrence after radical prostatectomy","volume":"106","author":"Thaxton","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022605342897900_B46","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1373\/clinchem.2011.169540","article-title":"Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology","volume":"57","author":"Wilson","year":"2011","journal-title":"Clin Chem"},{"key":"2020022605342897900_B47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"key":"2020022605342897900_B48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40279-014-0247-x","article-title":"Prevalence of doping use in elite sports: a review of numbers and methods","volume":"45","author":"de Hon","year":"2015","journal-title":"Sports Med"},{"key":"2020022605342897900_B49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/519033b","article-title":"Athlete testing: sports doping vastly underestimated","volume":"519","author":"Evans","year":"2015","journal-title":"Nature"},{"key":"2020022605342897900_B50","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1373\/clinchem.2014.226175","article-title":"Counterpoint: the quest for clean competition in sports: deterrence and the role of detection","volume":"60","author":"Bowers","year":"2014","journal-title":"Clin Chem"},{"key":"2020022605342897900_B51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/bjsports-2014-093526","article-title":"Anabolic agents: recent strategies for their detection and protection from inadvertent doping","volume":"48","author":"Geyer","year":"2014","journal-title":"Br J Sports Med"},{"key":"2020022605342897900_B52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/edrv-8-1-1","article-title":"Biological actions of androgens","volume":"8","author":"Mooradian","year":"1987","journal-title":"Endocr Rev"},{"key":"2020022605342897900_B53","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0015-0282(02)02968-0","article-title":"Androgen effects on bone and muscle","volume":"77","author":"Notelovitz","year":"2002","journal-title":"Fertil Steril"},{"key":"2020022605342897900_B54","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0015-0282(02)04850-1","article-title":"Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance","volume":"79","author":"Rickenlund","year":"2003","journal-title":"Fertil Steril"},{"key":"2020022605342897900_B55","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jms.1457","article-title":"Factors influencing the steroid profile in doping control analysis","volume":"43","author":"Mareck","year":"2008","journal-title":"J Mass Spectrom"},{"key":"2020022605342897900_B56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jat\/14.2.91","article-title":"Analysis of anabolic steroids using GC\/MS with selected ion monitoring","volume":"14","author":"Chung","year":"1990","journal-title":"J Anal Toxicol"},{"key":"2020022605342897900_B57","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1210\/jc.2011-0521","article-title":"Androgen sulfation in healthy UDP-glucuronosyl transferase 2B17 enzyme-deficient men","volume":"96","author":"Schulze","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022605342897900_B58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-3-540-79088-4_14","article-title":"The athlete's biological passport and indirect markers of blood doping","volume":"195","author":"Sottas","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"2020022605342897900_B59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1373\/clinchem.2011.162271","article-title":"The athlete biological passport","volume":"57","author":"Sottas","year":"2011","journal-title":"Clin Chem"},{"key":"2020022605342897900_B60","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/biostatistics\/kxl009","article-title":"Bayesian detection of abnormal values in longitudinal biomarkers with an application to T\/E ratio","volume":"8","author":"Sottas","year":"2007","journal-title":"Biostatistics"},{"key":"2020022605342897900_B61","first-page":"16","article-title":"The relation between athletic sports and prevalence of amenorrhea and oligomenorrhea in Iranian female athletes","volume":"1","author":"Dadgostar","year":"2009","journal-title":"Sports Med Arthrosc Rehabil Ther Technol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/62\/8\/1066\/32644615\/clinchem1066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/62\/8\/1066\/32644615\/clinchem1066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T10:36:20Z","timestamp":1582713380000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/62\/8\/1066\/5611928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,1]]},"published-print":{"date-parts":[[2016,8,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2016.256198","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,8,1]]},"published":{"date-parts":[[2016,8,1]]}}}